Human Pathology

Papers
(The H4-Index of Human Pathology is 19. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
Table of Contents63
Table of Contents52
Editorial board45
Inside front cover - Masthead40
Gradual and synergistic correlation of tumor thickness and histological grade in penile invasive carcinomas35
Editorial board34
High-grade B-cell lymphoma with concurrent MYC rearrangement and 11q aberrations: clinicopathologic, cytogenetic, and molecular characterization of 4 cases33
Intravascular adenomyomatosis: a morphologic variant of intravenous leiomyomatosis associated with endometriosis and potential for misdiagnosis31
Inside front cover - Masthead31
Morphologic spectrum of treatment-related changes in prostate tissue and prostate cancer: an updated review31
Inside front cover - Masthead29
Information for Authors26
Histopathology of autoimmune bullous dermatoses: what's new?23
Editorial board23
Clinicopathological features of and neoadjuvant therapy for human epidermal growth factor receptor 2-positive classic invasive lobular carcinoma22
Ancillary tests for hepatobiliary neoplasms: what we know and what we need to know22
Mantle cell lymphoma involving tonsils: a clinicopathologic study of 83 cases21
Thyroid-like low-grade nasopharyngeal papillary adenocarcinoma: a clinicopathological and molecular study of four cases20
ARID1A, BRG1, and INI1 deficiency in undifferentiated and dedifferentiated endometrial carcinoma: a clinicopathologic, immunohistochemical, and next-generation sequencing analysis of a case series fro20
Molecular alterations in primary and metastatic PEComa: insights from the AACR project GENIE data set19
Three pathologic criteria for reproducible diagnosis of colonic sessile serrated lesion versus hyperplastic polyp19
Alpha-methylacyl-CoA racemase (AMACR) protein is upregulated in early proliferative lesions of the breast irrespective of apocrine differentiation19
Genetic validation of a TSC2 immunohistochemistry assay in TSC/mTOR-pathway altered renal tumors19
Cutaneous vascular tumors: an updated review19
0.84951090812683